bet9¹ÙÍø announces Q2 FY1415 Unaudited Consolidated Financial Results

bet9¹ÙÍø appoints Ms.Punita Lal and Dr. Nachiket Mor as Independent Directors on its Board

bet9¹ÙÍø Medpro announces collaboration with world’s largest generic pharmaceutical company

The Medicines Patent Pool Adds New Sub-Licensing Agreements to Improve Access to Novel ARVs in Developing Countries

bet9¹ÙÍø strengthens its presence in Kenya

bet9¹ÙÍø licenses rights for innovative product

bet9¹ÙÍø enters into a licensing agreement with Gilead to increase access to Hepatitis C treatment

bet9¹ÙÍø announces a commercial collaboration with S&D Pharma to enter Czech Republic and Slovakia with affordable high quality alternatives

bet9¹ÙÍø enters the respiratory market in Germany and Sweden with affordable high quality alternatives

bet9¹ÙÍø announces Q1 FY1415 Unaudited Consolidated Financial Results

Subscribe to